ASH 2017: Are Experts Personalizing Therapy to the Genetics of a Patient’s Myeloma?

ASH 2017: Are Experts Personalizing Therapy to the Genetics of a Patient’s Myeloma?

User Photo
P2Professional

2 years
555 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Where do things stand now with personalizing myeloma therapy to a patients genetic profile? At the American Society of Hematology (ASH) 2017 conference in Atlanta, Esther Schorr speaks with Dr. Gareth Morgan, Director of the UAMS Myeloma Institute, about new oncogenes in myeloma. They also discuss the importance of testing at the time of myeloma diagnosis to set a treatment plan. Watch for this top myeloma experts take on the latest myeloma research.
Up Next Autoplay